ARS Pharmaceuticals (SPRY) EBITDA (2020 - 2026)
ARS Pharmaceuticals' EBITDA came in at -$61.05 million for Q2 2026, compared with -$47.34 million a year earlier.
Powered by 
Analysis
ARS Pharmaceuticals (SPRY) EBITDA (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, ARS Pharmaceuticals reported EBITDA of -$214.65 million; for FY2025, it came in at -$178.08 million.
- Going back by year, EBITDA was -$3 million in FY2024, -$67.42 million in FY2023, -$35.42 million in FY2022 and -$19.24 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly EBITDA in data going back to Q1 2020.
- Business Quant data shows SPRY's EBITDA at -$59.75 million (Q1 2026), -$41.05 million (Q4 2025) and -$52.8 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.50 Bn | 1,103.09 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 616.20 Bn | 534.73 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 500.82 Bn | 473.93 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 367.31 Bn | 321.69 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 297.77 Bn | 261.76 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.35 Bn | 235.04 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 235.40 Bn | 190.80 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 190.59 Bn | 164.79 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 169.39 Bn | 116.04 Bn | 10.94 Bn | 5.89 Bn |
| 10 | ARS Pharmaceuticals | 419.10 Mn | 275.30 Mn | 20.81 Mn | -61.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -61.05 Mn |
| Mar 31, 2026 | -59.75 Mn |
| Dec 31, 2025 | -41.05 Mn |
| Sep 30, 2025 | -52.80 Mn |
| Jun 30, 2025 | -47.34 Mn |
| Mar 31, 2025 | -36.90 Mn |
| Dec 31, 2024 | 47.23 Mn |
| Sep 30, 2024 | -21.65 Mn |
| Jun 30, 2024 | -15.32 Mn |
| Mar 31, 2024 | -13.18 Mn |
| Dec 31, 2023 | -10.23 Mn |
| Sep 30, 2023 | -17.88 Mn |
| Jun 30, 2023 | -20.58 Mn |
| Mar 31, 2023 | -18.69 Mn |
| Dec 31, 2022 | -15.43 Mn |
| Sep 30, 2022 | -6.62 Mn |
| Jun 30, 2022 | -6.38 Mn |
| Mar 31, 2022 | -6.89 Mn |
| Dec 31, 2021 | 46.83 Mn |
| Sep 30, 2021 | -22.48 Mn |
API Access
ARS Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=SPRY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "SPRY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=SPRY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();